Status:
UNKNOWN
Molecular Biomarkers Predicting Early Development of Endometrial Carcinoma
Lead Sponsor:
Università degli Studi di Ferrara
Conditions:
Cancer of Endometrium
Eligibility:
FEMALE
18+ years
Brief Summary
Endometrial carcinoma represents the most common gynaecological cancer and the sixth most frequent cancer among women worldwide. The 5-year survival of patients with stage I endometrial carcinoma is 7...
Eligibility Criteria
Inclusion
- age \> 18 years old
- patients subjected to endometrial biopsies with previous histopathologically negative and subsequent histopathologically positive for endometrial carcinoma
- patient informed consent
Exclusion
- \- Endometrial carcinoma patients without a previous non-tumour biopsy were excluded
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT05273099
Start Date
March 1 2022
End Date
December 1 2023
Last Update
April 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Section of Obstetrics and Gynecology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy
Ferrara, Italy